Wiley Bros. Aintree Capital, LLC Pfizer Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 562,920 shares of PFE stock, worth $14.3 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
562,920
Previous 362,153
55.44%
Holding current value
$14.3 Million
Previous $10.5 Million
42.5%
% of portfolio
0.19%
Previous 0.21%
Shares
16 transactions
Others Institutions Holding PFE
# of Institutions
3,373Shares Held
3.56BCall Options Held
106MPut Options Held
123M-
Vanguard Group Inc Valley Forge, PA519MShares$13.1 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.8 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.36 Billion0.31% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA155MShares$3.94 Billion0.78% of portfolio
-
Geode Capital Management, LLC Boston, MA121MShares$3.06 Billion0.25% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $142B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...